GSTM1 and coronary artery disorder: The TRICC trial, a study comparing restrictive versus liberal RBC transfusion in intensive care patients, found no difference in mortality through use of a restrictive transfusion policy (Hb transfusion threshold < 7 g/dL) in a subgroup of 257 patients with known ischemic heart disease [16].